Literature DB >> 20833182

Responses of diploid and triploid Pacific oysters Crassostrea gigas to Vibrio infection in relation to their reproductive status.

S De Decker1, J Normand, D Saulnier, F Pernet, S Castagnet, P Boudry.   

Abstract

Several Vibrio species are known to be pathogenic to the Pacific oyster Crassostrea gigas. Survival varies according to pathogen exposure and high mortality events usually occur in summer during gametogenesis. In order to study the effects of gametogenetic status and ploidy (a factor known to affect reproduction allocation in oysters) on vibriosis survival, we conducted two successive experiments. Our results demonstrate that a common bath challenge with pathogenic Vibrio splendidus and Vibrio aestuarianus on a mixture of mature, spawning and non-mature oysters can lead to significant mortality. Previous bath challenges, which were done using only non-mature oysters, had not produced mortality. Immunohistochemical analyses showed the affinity of Vibrio for gonadic tissues, highlighting the importance of sexual maturity for vibriosis infection processes in oysters. Mortality rate results showed poor repeatability between tanks, however, in this bath challenge. We then tested a standardized and repeatable injection protocol using two different doses of the same combination of two Vibrio species on related diploid and triploid oysters at four different times over a year. Statistical analyses of mortality kinetics over a 6-day period after injection revealed that active gametogenesis periods correspond to higher susceptibility to vibriosis and that there is a significant interaction of this seasonal effect with ploidy. However, no significant advantage of triploidy was observed. Triploid oysters even showed lower survival than diploid counterparts in winter. Results are discussed in relation to differing energy allocation patterns between diploid and triploid Pacific oysters. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20833182     DOI: 10.1016/j.jip.2010.09.003

Source DB:  PubMed          Journal:  J Invertebr Pathol        ISSN: 0022-2011            Impact factor:   2.841


  5 in total

1.  Use of OmpU porins for attachment and invasion of Crassostrea gigas immune cells by the oyster pathogen Vibrio splendidus.

Authors:  Marylise Duperthuy; Paulina Schmitt; Edwin Garzón; Audrey Caro; Rafael D Rosa; Frédérique Le Roux; Nicole Lautrédou-Audouy; Patrice Got; Bernard Romestand; Julien de Lorgeril; Sylvie Kieffer-Jaquinod; Evelyne Bachère; Delphine Destoumieux-Garzón
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  The bromotyrosine derivative ianthelline isolated from the arctic marine sponge Stryphnus fortis inhibits marine micro- and macrobiofouling.

Authors:  Kine O Hanssen; Gunnar Cervin; Rozenn Trepos; Julie Petitbois; Tor Haug; Espen Hansen; Jeanette H Andersen; Henrik Pavia; Claire Hellio; Johan Svenson
Journal:  Mar Biotechnol (NY)       Date:  2014-07-23       Impact factor: 3.619

3.  Autophagy plays an important role in protecting Pacific oysters from OsHV-1 and Vibrio aestuarianus infections.

Authors:  Pierrick Moreau; Kevin Moreau; Amélie Segarra; Delphine Tourbiez; Marie-Agnès Travers; David C Rubinsztein; Tristan Renault
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

4.  Oyster Versatile IKKα/βs Are Involved in Toll-Like Receptor and RIG-I-Like Receptor Signaling for Innate Immune Response.

Authors:  Baoyu Huang; Linlin Zhang; Fei Xu; Xueying Tang; Li Li; Wei Wang; Mingkun Liu; Guofan Zhang
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

5.  Can selection for resistance to OsHV-1 infection modify susceptibility to Vibrio aestuarianus infection in Crassostrea gigas? First insights from experimental challenges using primary and successive exposures.

Authors:  Patrick Azéma; Marie-Agnès Travers; Julien De Lorgeril; Delphine Tourbiez; Lionel Dégremont
Journal:  Vet Res       Date:  2015-12-09       Impact factor: 3.683

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.